Aortic valve homografis in adults: a clinical perspective

Mayo Clinic Proceedings

Volumn 73, Issue 3, 1998, Pages 231-238

  Staab, Michael E ^a   Nishimura, Rick A ^b   Dearani, Joseph A ^b   Orszulak, Thomas A ^b  

^a Division of Cardiovascular Diseases and Internal Medicine   (United States)

^b MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA GRAFT; AORTA VALVE DISEASE; AORTA VALVE REGURGITATION; AUTOPSY; DISEASE SEVERITY; ENDOCARDITIS; GRAFT PRESERVATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; REVIEW; SURGICAL TECHNIQUE; SURVIVAL RATE; THROMBOEMBOLISM;

EID: 0031892408     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/73.3.231     Document Type: Article

References (54)

1. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med 1996;335:407-416
2. O'Brien MF. Composite stentless xenograft for the aortic valve replacement: clinical evaluation of function. Ann Thorac Surg 1995;60(Suppl):S406-S409
3. Turpie AG, Gent M, Laupacis A, Latour Y, Gunstensen J, Basile F, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993:329:524529
4. Jones EL, Weintraub WS, Graver JM, Guyton RA, Cohen CL, Corrigan VE, et al. Ten-year experience with the porcine bioprosthetic valve: interrelationship of valve survival and patient survival in 1,050 valve replacements. Ann Thorac Surg 1990;49:370-383
5. Grunkemeier GL, Jamieson WR, Miller DC, Starr A. Actuarial versus actual risk of porcine structural valve deterioration. J Thorac Cardiovasc Surg 1994;108:709-718
6. Fann Jl, Miller DC, Moore KA, Mitchell RS, Oyer PE, Stinson EB, et al. Twenty-year clinical experience with porcine bioprostheses. Ann Thorac Surg 1996;62:1301-1311
7. Cohn LH, Lipson W. Selection and complications of cardiac valvular prostheses. In: Baue AE, Geha AS, Hammond GL, Laks H, Naunheim KS, editors. Glenn's Thoracic and Cardiovascular Surgery. Vol 2. 6th ed. Stamford (CT): Appleton & Lange: 1996. pp 2043-2055
8. O'Brien MF. Homografts and autografts. In: Baue AE, Geha AS, Hammond GL, Laks H, Naunheim KS, editors. Glenn's Thoracic and Cardiovascular Surgery. Vol 2. 6th ed. Stamford (CT): Appleton & Lange; 1996. pp 2005-2042
9. Murray G. Homologous aortic-valve-segment transplants as surgical treatment for aortic and mitral insufficiency. Angiology 1956;7:466471
10. Ross DN. Homograft replacement of the aortic valve. Lancet 1962;2:487
11. Barratt-Boyes BG. Homograft aortic valve replacement and aortic incompetence and stenosis. Thorax 1964:19:131-150
12. Daly RC, Orszulak TA, Schaff HV, McGovern E, Wallace RB. Long term results of aortic valve replacement with nonviable homografts. Circulation 1991;84(Suppl 3):III81-III88
13. Gonzalez-Lavin L, Spotnitz AJ, Mackenzie JW, Gu J, Gad! IK, Gullo J, et al. Homograft valve durability: host or donor influence? Heart Vessels 1990:5:102-106
14. Schoen FJ, Levy RJ. Pathology of substitute heart valves: new concepts and developments. J Card Surg 1994;9(Suppl):222-227
15. Grunkemeier GL, Bodnar E. Comparison of structural valve failure among different 'models' of homograft valves. J Heart Valve Dis 1994:3:556-560
16. Crescenzo DG, Hubert SL, Messier RH Jr, Domkowski PW, Barrick MK, Lange PL, et al. Human cryopreserved homografts: electron microscopic analysis of cellular injury. Ann Thorac Surg 1993;55:2530
17. Fischlein T, Schutz A, Uhlig A, Frey R, Krupa W, Babic R, et al. Integrity and viability of homograft valves. Eur J Cardiothorac Surg 1994:8:425-430
18. Shaddy RE, Hunter DD, Osborn KA, Lambert LM, Minich LL, Hawkins JA, et al. Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pédiatrie surgery. Circulation 1996:94:1063-1067
19. Yacoub M, Rasmi NR, Sundt TM, Lund 0, Boyland E, Radley-Smith R, et al. Fourteen-year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg 1995;110:186-193
20. Kirklin JK, Smith D, Novick W, Naftel DC, Kirklin JW, Pacifico AD, et al. Long-term function of cryopreserved aortic homografts: a ten-year study. J Thorac Cardiovasc Surg 1993;106:154-165
21. O'Brien MF, Stafford EG, Gardner MA, Pohlner PG, Tesar PJ, Cochrane AD, et al. Allograft aortic valve replacement: long-term follow-up. Ann Thorac Surg 1995;60(Suppl):S65-S70
22. Dearani JA, Orszulak TA, Daly RC, Phillips MR, Miller FA, Danielson GK, et al. Comparison of techniques for implantation of aortic valve allografts. Ann Thorac Surg 1996;62:1069-1075
23. Ross DN. Replacement of aortic and mitral valves with a pulmonary autograft. Lancet 1967;2:956-958
24. Chambers JC, Somerville J, Stone S, Ross DN. Pulmonary autograft procedure for aortic valve disease: long-term results of the pioneer series. Circulation 1997:96:2206-2214
25. Angell WW, Oury JH, Lambert! JJ, Koziol J. Durability of the viable aortic allograft. J Thorac Cardiovasc Surg 1989;98:48-55
26. Knott-Craig CJ, Elkins RC, Stelzer PL, Randolph JD, McCue C, Wright PA, et al. Homograft replacement of the aortic valve and root as a functional unit. Ann Thorac Surg 1994;57:1501-1505
27. Tuna 1C, Orszulak TA, Schaff HV, Danielson GK. Results of homograft aortic valve replacement for active endocarditis. Ann Thorac Surg 1990:49:619-624
28. Dearani JA, Orszulak TA, Schaff HV, Daly RC, Anderson BJ, Danielson GK. Results of allograft aortic valve replacement for complex endocarditis. J Thorac Cardiovasc Surg 1997;113:285-291
29. Petrou M, Wong K, Albertucci M, Brecker SJ, Yacoub MH. Evaluation of unstented aortic homografts for the treatment of prosthetic aortic valve endocarditis. Circulation 1994;90(Suppl 2):II198-II204
30. Vogt PR, von Segesser LK, Jenni R, Niederhäuser U, Genoni M, Künzli A, et al. Emergency surgery for acute infective aortic valve endocarditis: performance of cryopreserved homografts and mode of failure. Eur J Cardiothorac Surg 1997:11:53-61
31. McGiffm DC, Kirklin JK. The impact of aortic valve homografts on the treatment of aortic prosthetic valve endocarditis. Semin Thorac Cardiovasc Surg 1995;7:25-31
32. Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995:333:1117
33. Gott VL, Cameron DE, Reitz BA, Pyeritz RE. Current diagnosis and prescription for the Marfan syndrome: aortic root and valve replacement. J Card Surg 1994:9:177-181
34. Gott VL, Gillinov AM, Pyeritz RE, Cameron DE, Reitz BA, Green BS, et al. Aortic root replacement: risk factor analysis of a seventeen-year experience with 270 patients. J Thorac Cardiovasc Surg 1995; 109:536-544
35. Prager RL, Deschner W, Kong B, Fischer CR, Byrne J, Hance L, et al. Early experience with homograft aortic root replacement for complex aortic pathology. Surgery 1993:114:794-798
36. Glazier JJ, Verwilghen J, Donaldson RM, Ross DN. Treatment of complicated prosthetic aortic valve endocarditis with annular abscess formation by homograft aortic root replacement. J Am Coll Cardiol 1991;17:1177-1182
37. Rahimtoola SH. The problem of valve prosthesis-patient mismatch. Circulation 1978:58:20-24
38. Jaffe WM, Coverdale HA, Roche AH, Whitlock RM, Neutze JM, Barratt-Boyes BG. Rest and exercise hemodynamics of 20 to 23 mm allograft, Medtronic Intact (porcine), and St. Jude Medical valves in the aortic position. J Thorac Cardiovasc Surg 1990:100:167174
39. Bodnar E, Matsuki 0, Parker R, Ross DN. Viable and nonviable aortic homografts in the subcoronary position: a comparative study. Ann Thorac Surg 1989:47:799-805
40. Doty DB, Michielon G, Wang ND, Cain AS, Millar RC. Replacement of the aortic valve with cryopreserved aortic allograft. Ann Thorac Surg 1993:56:228-235
41. Shapira OM, Shemin RJ. Aortic valve replacement with cryopreserved allografts: mid-term results. J Card Surg 1994;9:292-297
42. O'Brien MF, Finney RS, Stafford EG, Gardner MA, Pohlner PG, Tesar PJ, et al. Root replacement for all allograft aortic valves: preferred technique or too radical? Ann Thorac Surg 1995;60(Suppl):S87-S91
43. Smith JA, Westlake GW, Mullerworth MH, Skillington PD, Tatoulis J. Excellent long-term results of cardiac valve replacement with the St Jude Medical valve prosthesis. Circulation 1993;88(Suppl 2):II491154
44. Khan S, Chaux A, Matloff J, Blanche C, DeRobertis M, Kass R, et al. The St. Jude Medical valve: experience with 1,000 cases. J Thorac Cardiovasc Surg 1994;108:1010-1019
45. Aoyagi S, Oryoji A, Nishi Y, Tanaka K, Kosuga K, Oishi K. Long-term results of valve replacement with the St. Jude Medical valve. J Thorac Cardiovasc Surg 1994;108:1021-1029
46. Masters RG, Pipe AL, Walley VM, Keon WJ. Comparative results with the St. Jude Medical and Medtronic Hall mechanical valves. J Thorac Cardiovasc Surg 1995;110:663-671
47. Gödje ÖL, Fischlein T, Adelhard K, Notiert G, Klinner W, Reichart B. Thirty-year results of Starr-Edwards prostheses in the aortic and mitral position. Ann Thorac Surg 1997:63:613-619
48. Orszulak TA, Schaff HV, Puga FJ, Danielson GK, Mullany CJ, Anderson BJ, et al. Event status of the Starr-Edwards aortic valve to 20 years: a benchmark for comparison. Ann Thorac Surg 1997;63:620626
49. Akins CW. Long-term results with the Medtronic-Hall valvular prosthesis. Ann Thorac Surg 1996;61:806-813
50. Jamieson WR, Munro AI, Miyagishima RT, Alien P, Burr LH, Tyers GF. Carpentier-Edwards standard porcine bioprosthesis: clinical performance to seventeen years. Ann Thorac Surg 1995;60:9991006
51. Glower DD, White WD, Hatton AC, Smith LR, Young WG, Wolfe WG, et al. Determinants of reoperation after 960 valve replacements with Carpentier-Edwards prostheses. J Thorac Cardiovasc Surg 1994; 107:381-392
52. Burdon TA, Miller DC, Over PE, Mitchell RS, Stinson EB, Starnes VA, et al. Durability of porcine valves at fifteen years in a representative North American patient population. J Thorac Cardiovasc Surg 1992; 103:238-251
53. Cohn LH, Collins JJ Jr, DiSesa VJ, Couper GS, Peigh PS, Kowalker W, et al. Fifteen-year experience with 1678 Hancock porcine bioprosthetic heart valve replacements. Ann Surg 1989:210:435442
54. Bortolotti U, Milano A, Mazzaro E, Thiene G, Talent! E, Casarotto D. Hancock II porcine bioprosthesis: excellent durability at intermediateterm follow-up. J Am Coll Cardiol 1994;24:676-682